The burden of central anticholinergic drugs increases pain and cognitive dysfunction. More knowledge about drug-interactions needed

The burden of central anticholinergic drugs increases pain and cognitive dysfunction. More... In this issue of the Scandinavian Journal of Pain, Flavia Karine Rigo and co-workers in Brazil report on their studies that revealed a cholinergic mechanism of the antinociceptive action of a peptide from a spider-toxin [1]. Their study is well done and well reported, following the ARRIVE-recommendations for doing and reporting animal research [2]. They found that in a chronic nerve/nerve-root constriction model (model of neuropathic pain) this peptide causes a robust reduction in mechanical withdrawal (~reduction of neuropathic pain), and in pain caused by paw-injection of capsaicin [1]. The mechanism of this effect was clearly demonstrated to be via inhibiting acetylcholine-esterase (AChE) in the CNS (spinal cord). Being a peptide, they had to inject this peptide intrathecally (IT), directly in to the cerebrospinal fluid (CSF).1More attention needed on benefits of cholinergic drugs and on the negative effects on cognitive functions and pain from anticholinergic drugsWe publish their study-report [1] also because clinicians need more knowledge and attention to the beneficial effects on cognitive functions and pain by cholinergic drugs, but even more so we need more knowledge about the burden of the multitude of anticholinergic drugs. Patients suffering from pain, especially our elderly patients, are often exposed to http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Scandinavian Journal of Pain de Gruyter

The burden of central anticholinergic drugs increases pain and cognitive dysfunction. More knowledge about drug-interactions needed

Loading next page...
 
/lp/degruyter/the-burden-of-central-anticholinergic-drugs-increases-pain-and-bqVsDHTADR
Publisher
De Gruyter
Copyright
© 2017 Scandinavian Association for the Study of Pain
ISSN
1877-8860
eISSN
1877-8879
D.O.I.
10.1016/j.sjpain.2017.09.022
Publisher site
See Article on Publisher Site

Abstract

In this issue of the Scandinavian Journal of Pain, Flavia Karine Rigo and co-workers in Brazil report on their studies that revealed a cholinergic mechanism of the antinociceptive action of a peptide from a spider-toxin [1]. Their study is well done and well reported, following the ARRIVE-recommendations for doing and reporting animal research [2]. They found that in a chronic nerve/nerve-root constriction model (model of neuropathic pain) this peptide causes a robust reduction in mechanical withdrawal (~reduction of neuropathic pain), and in pain caused by paw-injection of capsaicin [1]. The mechanism of this effect was clearly demonstrated to be via inhibiting acetylcholine-esterase (AChE) in the CNS (spinal cord). Being a peptide, they had to inject this peptide intrathecally (IT), directly in to the cerebrospinal fluid (CSF).1More attention needed on benefits of cholinergic drugs and on the negative effects on cognitive functions and pain from anticholinergic drugsWe publish their study-report [1] also because clinicians need more knowledge and attention to the beneficial effects on cognitive functions and pain by cholinergic drugs, but even more so we need more knowledge about the burden of the multitude of anticholinergic drugs. Patients suffering from pain, especially our elderly patients, are often exposed to

Journal

Scandinavian Journal of Painde Gruyter

Published: Oct 1, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off